Analysis of EFX results with AI-based digital pathology underscores the potential value in evaluating histopathology response ...

The model proposed in this paper hypothesises that the pathology and the response to treatment are different in these presentations, and that interventions should be tailored to the pathology.

FibroNest digital pathology in liver biopsies from patients with MASH FibroNest digital pathology augmented image for ...

Alterity Therapeutics (ASX: ATH, NASDAQ: ATHE) (“Alterity” or “the Company”), a biotechnology company dedicated to developing disease modifying treatments for neurodegenerative diseases, today ...

In 2019, reports of a rapidly progressive dementia cluster in New Brunswick raised public and media concerns about a ...

A newly published peer-reviewed article on a study conducted at The Ohio State University Wexner Medical Center confirms that Ibex Breast, an AI-powered diagnostic support solution developed by Ibex ...

Q1 2025 Earnings Call Transcript May 9, 2025 Kymera Therapeutics, Inc. beats earnings expectations. Reported EPS is $-0.82, expectations were $-0.92. Justine Koenigsberg: Good morning, and welcome to ...

Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision genetic medicine for rare diseases, today reported ...

The presentation will be available on the Rectify website at https://rectifypharma.com/publications/.

Good day, and welcome to the BioCryst First Quarter 2025 Earnings Conference Call. All participants will be in listen-only ...

WATERTOWN, Mass., May 07, 2025 (GLOBE NEWSWIRE) -- Vigil Neuroscience, Inc. (Nasdaq: VIGL), a clinical-stage biotechnology ...

Non-Aspergillus invasive molds infections (NAIMIs) are uncommon but devastating causes of infection in the peri-hematopoietic ...